Our studies also showed that AS-IV attenuated the DAI and MPO activity, downregulate the expression of Tnf-α and Il-1β and increase the level of Il-10 and Tgf-β in a dose-dependently manner in DSS-induced colitis mice. This evidence concerns the gene TGFB1 and colitis.